NCT02083133已完成不适用
Dosing Strategies in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis (DOSE-HD Study)
Cook County Health1 个研究点 分布在 1 个国家目标入组 496 人开始时间: 2013年10月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 496
- 试验地点
- 1
- 主要终点
- Hypoglycemia
研究概览
简要总结
The purpose of this study is to assess whether the current recommendation for a 50% dose reduction in insulin for diabetic patients with a creatinine clearance (CrCl) ≤15 mL/min or on hemodialysis results in an increased number of hypoglycemic episodes.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 99 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Inpatient men and women 18 years of age and older with a diagnosis of type 2 diabetes mellitus (T2DM) with CrCl ≥60, 16-59 or ≤15 milliliters/minute.
排除标准
- •Patients less than 18 years of age, pregnant patients
结局指标
主要结局
Hypoglycemia
时间窗: Last 5 years
次要结局
未报告次要终点
研究者
Pete Antonopoulos
Clinical Pharmacist- Principal Investigator
Cook County Health
研究点 (1)
Loading locations...
相似试验
已完成
不适用
The Adjustment of Doses in Diabetes Mellitus Type IDiabetes Mellitus, Type 1NCT06055829Liwa College1
终止
3 期
Urokinase Therapy in Patients With Diabetic Foot SyndromeIschemiaDiabetic FootArterial Occlusive DiseaseNCT00823225medac GmbH5
已完成
不适用
Clinical Characteristics and Practice Patterns of Type 2 Diabetes Mellitus Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDVDiabetes Mellitus, Type 2NCT03092752Boehringer Ingelheim162,116
已完成
不适用
Dose Reduction and Discontinuation With Anti-Fibrotic MedicationsIdiopathic Pulmonary FibrosisNCT05779007Boehringer Ingelheim2,778
已完成
1 期
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Insulin Icodec in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2NCT04582435Novo Nordisk A/S46